NasdaqGM - Nasdaq Real Time Price USD
ANI Pharmaceuticals, Inc. (ANIP)
62.00
-0.30
(-0.48%)
At close: 4:00:02 PM EDT
62.00
0.00
(0.00%)
After hours: 4:37:59 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 402,414 | 11 |
| Sales | 59,831 | 14 |
| Net Shares Purchased (Sold) | 342,583 | 25 |
| Total Insider Shares Held | 2.2M | -- |
| % Net Shares Purchased (Sold) | 18.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| COOK MEREDITH General Counsel | Sale at price 68.96 per share. | Direct | 27,584 | Apr 14, 2025 |
| DAVIS KRISTA Officer | Sale at price 65.00 per share. | Direct | 121,290 | Mar 19, 2025 |
| COOK MEREDITH General Counsel | Sale at price 63.33 per share. | Direct | 25,332 | Mar 13, 2025 |
| DAVIS KRISTA Officer | Sale at price 60.86 per share. | Direct | 60,860 | Mar 7, 2025 |
| GUTWERG ORI Officer | Sale at price 60.00 - 60.03 per share. | Direct | 323,049 | Mar 5, 2025 |
| GUTWERG ORI Officer | Conversion of Exercise of derivative security at price 31.49 per share. | Direct | 9,447 | Mar 5, 2025 |
| DAVIS KRISTA Officer | Sale at price 60.20 per share. | Direct | 60,200 | Feb 21, 2025 |
| COOK MEREDITH General Counsel | Sale at price 59.54 per share. | Direct | 23,816 | Feb 13, 2025 |
| CAREY STEPHEN P. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LALWANI NIKHIL SURESH Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| GUTWERG ORI Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| MUTZ CHRISTOPHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ROWLAND THOMAS ANDREW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| SHANMUGAM MUTHUSAMY Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| GASSERT CHAD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| COOK MEREDITH General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DAVIS KRISTA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| COOK MEREDITH General Counsel | Sale at price 53.92 per share. | Direct | 21,568 | Jan 13, 2025 |
| CAREY STEPHEN P. Chief Financial Officer | Sale at price 55.79 per share. | Direct | 418,425 | Dec 17, 2024 |
| COOK MEREDITH General Counsel | Sale at price 56.24 per share. | Direct | 14,060 | Dec 13, 2024 |
| DAVIS KRISTA Officer | Sale at price 60.00 per share. | Direct | 60,000 | Dec 11, 2024 |
| LALWANI NIKHIL SURESH Chief Executive Officer | Sale at price 57.95 - 58.30 per share. | Direct | 1,941,442 | Nov 26, 2024 |
| LALWANI NIKHIL SURESH Chief Executive Officer | Conversion of Exercise of derivative security at price 29.00 per share. | Direct | 870,000 | Nov 26, 2024 |
| MUTZ CHRISTOPHER Officer | Sale at price 57.70 per share. | Direct | 375,050 | Nov 15, 2024 |
| COOK MEREDITH General Counsel | Sale at price 61.36 per share. | Direct | 15,340 | Nov 13, 2024 |
| COOK MEREDITH General Counsel | Sale at price 57.19 per share. | Direct | 14,298 | Oct 14, 2024 |
| COOK MEREDITH General Counsel | Sale at price 56.82 per share. | Direct | 14,205 | Sep 13, 2024 |
| COOK MEREDITH General Counsel | Sale at price 59.62 per share. | Direct | 14,905 | Aug 13, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 62.00 per share. | Indirect | 170,066 | Jul 18, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 63.16 - 64.27 per share. | Indirect | 3,011,592 | Jul 17, 2024 |
| COOK MEREDITH General Counsel | Sale at price 64.91 per share. | Direct | 16,228 | Jul 12, 2024 |
| GASSERT CHAD Officer | Sale at price 63.44 per share. | Indirect | 1,268,800 | Jul 1, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 58.90 per share. | Indirect | 1,178,000 | Jun 21, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 59.86 - 61.41 per share. | Indirect | 1,817,663 | Jun 20, 2024 |
| COOK MEREDITH General Counsel | Sale at price 63.80 per share. | Direct | 15,950 | Jun 13, 2024 |
| MARKEN JAMES G Officer | Conversion of Exercise of derivative security at price 49.51 - 57.06 per share. | Direct | 661,366 | Jun 7, 2024 |
| GUTWERG ORI Officer | Sale at price 67.00 per share. | Direct | 199,995 | Jun 5, 2024 |
| CAREY STEPHEN P. Chief Financial Officer | Sale at price 63.58 per share. | Direct | 317,900 | Jun 4, 2024 |
| GASSERT CHAD Officer | Sale at price 64.41 per share. | Indirect | 1,288,200 | Jun 3, 2024 |
| WALSH PATRICK D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| LEONARD MATTHEW J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| THOMA JEANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| PERA ANTONIO R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| HAUGHEY THOMAS J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| TANNENBAUM RENEE P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 21, 2024 |
| MUTZ CHRISTOPHER Officer | Sale at price 61.61 per share. | Direct | 123,220 | May 21, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 61.81 per share. | Indirect | 794,568 | May 20, 2024 |
| SHANMUGAM MUTHUSAMY Officer and Director | Sale at price 62.09 - 65.86 per share. | Indirect | 2,391,121 | May 17, 2024 |
| TANNENBAUM RENEE P Director | Sale at price 63.87 per share. | Direct | 127,740 | May 16, 2024 |
| LALWANI NIKHIL SURESH Chief Executive Officer | Sale at price 66.10 per share. | Direct | 1,101,821 | May 14, 2024 |
Related Tickers
ANIK Anika Therapeutics, Inc.
12.41
+4.73%
PCRX Pacira BioSciences, Inc.
23.40
-6.74%
COLL Collegium Pharmaceutical, Inc.
29.80
+0.81%
ETON Eton Pharmaceuticals, Inc.
17.07
-1.61%
HROW Harrow, Inc.
26.27
-1.46%
IRWD Ironwood Pharmaceuticals, Inc.
0.6842
-6.76%
AVDL Avadel Pharmaceuticals plc
9.03
-5.84%
AKBA Akebia Therapeutics, Inc.
2.4800
+2.06%
SIGA SIGA Technologies, Inc.
5.94
0.00%
NBIX Neurocrine Biosciences, Inc.
116.87
-2.96%